1. Home
  2. ESPR vs IRBT Comparison

ESPR vs IRBT Comparison

Compare ESPR & IRBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • IRBT
  • Stock Information
  • Founded
  • ESPR 2008
  • IRBT 1990
  • Country
  • ESPR United States
  • IRBT United States
  • Employees
  • ESPR N/A
  • IRBT N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • IRBT Consumer Electronics/Appliances
  • Sector
  • ESPR Health Care
  • IRBT Consumer Discretionary
  • Exchange
  • ESPR Nasdaq
  • IRBT Nasdaq
  • Market Cap
  • ESPR 319.2M
  • IRBT 257.0M
  • IPO Year
  • ESPR 2013
  • IRBT N/A
  • Fundamental
  • Price
  • ESPR $2.33
  • IRBT $6.65
  • Analyst Decision
  • ESPR Buy
  • IRBT Hold
  • Analyst Count
  • ESPR 4
  • IRBT 2
  • Target Price
  • ESPR $8.17
  • IRBT $13.00
  • AVG Volume (30 Days)
  • ESPR 3.4M
  • IRBT 1.1M
  • Earning Date
  • ESPR 11-07-2024
  • IRBT 11-06-2024
  • Dividend Yield
  • ESPR N/A
  • IRBT N/A
  • EPS Growth
  • ESPR N/A
  • IRBT N/A
  • EPS
  • ESPR N/A
  • IRBT N/A
  • Revenue
  • ESPR $295,451,000.00
  • IRBT $817,355,000.00
  • Revenue This Year
  • ESPR $199.60
  • IRBT N/A
  • Revenue Next Year
  • ESPR $19.36
  • IRBT $4.94
  • P/E Ratio
  • ESPR N/A
  • IRBT N/A
  • Revenue Growth
  • ESPR 187.12
  • IRBT N/A
  • 52 Week Low
  • ESPR $0.87
  • IRBT $5.83
  • 52 Week High
  • ESPR $3.40
  • IRBT $42.14
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 54.58
  • IRBT 39.99
  • Support Level
  • ESPR $2.05
  • IRBT $6.55
  • Resistance Level
  • ESPR $2.25
  • IRBT $10.60
  • Average True Range (ATR)
  • ESPR 0.12
  • IRBT 0.74
  • MACD
  • ESPR -0.00
  • IRBT -0.15
  • Stochastic Oscillator
  • ESPR 61.54
  • IRBT 9.01

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About IRBT iRobot Corporation

iRobot Corp is a united state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online store. The company derives its revenue from the product sales. It sells the products across the United States and around the world.

Share on Social Networks: